FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Sep 30, 2009
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on September 30, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- September 30, 2009
- Product Type
- Biologics
View Company Profile
ID · e7826534-30dd-4a8f-af28-ea60e18a422e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 615024
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(c)Thorough investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 26, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 1, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 25, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 27, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 2, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1122680 - 2020-02-26
- FDA Inspection 1057025 - 2018-06-01
- FDA Inspection 964006 - 2016-01-25
- FDA Inspection 820128 - 2013-02-27
- FDA Inspection 707931 - 2011-02-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.